Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)

29.75
0.00
(0.00%)
As of 9:16:29 AM GMT+8. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Dongmao Su Chairman & GM -- -- --
Hui-Zhen Huang Finance Manager -- -- --

Chi Sheng Pharma & Biotech Co., Ltd

No. 3, Shih Chen Road
Hsin Chu Industrial Park Hukou
Hsinchu, 30352
Taiwan
886 3 598 3811 https://www.cscp.com.tw
Sector: 
Healthcare

Description

Chi Sheng Pharma & Biotech Co., Ltd engages in the manufacturing, processing, sale, and import and export trade of pharmaceuticals, medical products, cosmetics, health foods, and medical equipment in Taiwan and internationally. Its products portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerves agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and anti-asthmas; gastro-intestinal preparations; local anesthetic preparations; hemodialysis concentrate and external solutions; peritoneal dialysis solutions; and others. The company also offers medical devices, fat emulsion products, anesthetic products, hemostatics solutions, food products, functional drinks, skin care products, and veterinary medicinal products. In addition, it offers externally applied medicines, including contact lens, salt, and iodine solutions. Chi Sheng Pharma & Biotech Co., Ltd was founded in 1962 and is headquartered in Hsinchu, Taiwan.

Corporate Governance

Chi Sheng Pharma & Biotech Co., Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

August 23, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers